Human immunodeficiency virus infection

Sarcoidosis

Volumn , Issue , 2012, Pages 345-356

  Booth, Helen L ^a   Miller, Robert F ^b  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84878158779     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (47)

1. Ailani J, Graber J, Fagan I et al. (2009). Neurosarcoidosis in a patient with AIDS. AIDS Reader, 17 November.
2. Almeida FA, Sager JS, Eiger G (2006). Coexistent sarcodiosis and HIV infection: an immunological paradox. J Infect 52: 195-201.
3. Amin DN, Sperber K, Brown LK et al. (1992). Positive Kveim test in patients with coexisting sarcoidosis and human immunodeficiency virus infection. Chest 101: 1454-6.
4. Bhaskaran K, Hamouda O, Sannes M et al. (2008). Changes in the risk of death after HIV seroconversion compared with mortality in the general population. J Am Med Assoc 300: 51-9.
5. Blanche P, Gombert B, Rollot F et al. (2000). Sarcoidosis in a patient with acquired immunodeficiency syndrome treated with interleukin-2. Clin Infect Dis 31: 1493-4.
6. Connors M, Kovacs JA, Krevat S et al. (1997). HIV induces changes in CD4-T-cell phenotype and depletions within the CD4-T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat Med 3: 533-40.
7. Coots L, Lazarus AA (1989). Sarcoidosis diagnosed in a patient with known HIV infection. Chest 96: 201-2.
8. Corda L, Benerecetti D, Ungari M et al. (1996). Kaposi’s disease and sarcoidosis. Eur Respir J 9: 383-5.
9. Ferrand RA, Cartledge JD, Connolly J et al. (2007). Immune reconstitution sarcoidosis presenting with hypercalcaemia and renal failure in HIV infection. Int J STD AIDS 18: 138-9.
10. Foulon G, Wislez W, Naccache J-M et al. (2004). Sarcoidosis in HIVinfected patients in the era of highly active antiretroviral therapy. Clin Infect Dis 38: 418-25.
11. French MA, Lenzo N, John M et al. (2000). Immune restoration disease after the treatment of immunodeficient HIV infected patients with highly active antiretroviral therapy. HIV Med 1(2): 107-15.
12. Gao X, Nelson GW, Karacki P et al. (2001). Effect of a single amino acid change in MHC class 1 molecules in the rate of progression to AIDS. New Engl J Med 344: 1688-75.
13. Gomez V, Smith PR, Burack J et al. (2000). Sarcoidosis after antiretroviral therapy in a patient with acquired immunodeficiency syndrome. Clin Infect Dis 31: 1278-80.
14. Gowda KS, Mayers I, Shafran SD (1990). Concomitant sarcoidosis and HIV infection. Can Med Assoc J 142: 136-7.
15. Granieri J, Wisniewski JJ, Graham RC et al. (1995). Sarcoid myopathy in a patient with human immunodeficiency virus infection. Southern Med J 88: 591-5.
16. Hall HI, Song R, Rhodes P et al. (2008a). Estimation of HIV incidence in the United States. J Am Med Assoc 300: 520-9.
17. Hall HI, An Q, Hutchinson AB, Sansom S (2008b). Estimating the lifetime risk of a diagnosis of the HIV infection in 33 states, 2004-2005. J Acquir Immun Def Synd 49: 294-7.
18. Haramati LB, Lee G, Singh A et al. (2001). Newly diagnosed pulmonary sarcoidosis in HIV-infected patients. Radiology 218: 242-6.
19. Hendel H, Caillat-Zucman S, Lebuanec H et al. (1999). New class 1 and class II HLA alleles strongly associate with opposite patterns of progression to AIDS. J Immunol 162: 6942-6.
20. Hill KA, Till M, Laskin WB (2003). Pulmonary symptoms and lymphadenopathy in a human-immunodeficiency virus-infected woman. Arch Pathol Lab Med 127: 111.
21. Hunninghake GW, Crystal RG (1981). Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphcoyte activity at sites of disease activity. New Engl J Med 305: 429-34.
22. Hunninghake GW, Bedell GN, Zavala DC et al. (1983). Role of interleukin-2 release by lung cells in active pulmonary sarcoidosis. Am Rev Respir Dis 128: 634-8.
23. Jahn A, Floyd S, Crampin AC et al. (2008). Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi. Lancet 371: 1603-11.
24. Just JJ (1995). Genetic predisposition to HIV-1 infection and acquired immunodeficiency virus syndrome: a review of the literature examining associations with HLA. Hum Immunol 44: 159-66.
25. Kadakia J, Kiyabu M, Sharma OP et al. (1993). Granulomatous response to Pneumocystis carinii in patients infected with HIV. Sarcoidosis 104: 352-61.
26. Lassalle S, Selve E, Hofman V et al. (2006). Sarcoid-like lesions associated with the immune restoration inflammatory syndrome in AIDS: absence of polymerase chain reaction detection of Mycobacterium tuberculosis in granulomas isolated by laser capture microdissection. Virchows Arch 449: 689-96.
27. Lawn SD, Bekker LG, Miller RF (2005). Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis 5: 361-73.
28. Lee AK, Chronister CL (1999). Sarcodiosis-related anterior uveitis in a patients with human immunodeficiency virus. J Am Optom Assoc 70: 384-90.
29. Lenner R, Bregman Z, Teirstein AS et al. (2001). Recurrent pulmonary sarcodiosis in HIV-infected patients receiving highly active antiretroviral therapy. Chest 119: 978-81.
30. Moore RD, Chaisson RE (1999). Natural history of HIV infections in the era of combination antiretroviral therapy. AIDS 13: 1933-42.
31. Morris DG, Jasmer RM, Huang L et al. (2003). Sarcoidosis following HIV infection: evidence for CD4-lymphocyte dependence. Chest 124: 929-35.
32. Murdoch DM, Venter WDF, van Rie A et al. (2007). Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options. AIDS Res Ther 4: 9.
33. Naccache J-M, Antoine M, Wislez M et al. (1999). Sarcoid-like pulmonary disorder in human immunodeficiency virus-infected patients receiving antiretroviral therapy. Am J Respir Crit Care Med 159: 2009-13.
34. Newman TG, Minkowitz S, Hanna A et al. (1992). Coexistent sarcoidosis and HIV infection: a comparison of bronchoalveolar and peripheral blood lymphocytes. Chest 102: 1899-901.
35. Noursadeghi M, Katz DR, Miller RF (2006). HIV-1 infection of mononuclear phagocytic cells: the case for bacterial innate immune deficiency in AIDS. Lancet Infect Dis 6: 794-804.
36. Okosun J, Martin F, Murphy M et al. (2008). Sarcoid-like immune restoration inflammatory syndrome (IRIS) presenting with hypercalcaemia and renal failure in HIV infection. HIV Med 9(Suppl. 1): 31.
37. Papadaki TG, Kafkala C, Zacharopoulos IP et al. (2006). Conjunctival non-caseating granulomas in a human immunodeficiency virus positive patient attributed to sarcoidosis. Ocul Immunol Inflamm 14: 309-11.
38. Pietinalho A, Hirago Y, Hosoda Y et al. (1995). The frequency of sarcoidosis in Finland and Hokkaido, Japan: a comparative epidemiology study. Sarcoidosis 12: 61-7.
39. Poignard P, Sabbe R, Pichio GR et al. (1999). Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo. Immunity 10: 431-8.
40. Rosenberg ES, Billingsley JM, Caliendo AM et al. (1997). Vigorous HIV-1 specific CD4-T-cell responses associated with control of viraemia. Science 278: 1447-50.
41. Sato H, Grutters JC, Pantelides P et al. (2002). HLA-DQB1*0201 a marker for good prognosis in British and Dutch patients with sarcoidosis. Am J Respir Cell Mol Biol 27: 406-12.
42. Shelbourne SA, Hamill RJ, Rodriguez-Barradas MC et al. (2002). Immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. Medicine (Baltimore) 81: 213-27.
43. Trevenzoli M, Cattelan AM, Marino F et al. (2003). Sarcoidosis and HIV infection: a case report and a review of the literature. Postgrad Med J 79: 535-8.
44. Viani RM (2002). Sarcoidosis and interstitial nephritis in a child with acquired immunodeficiency syndrome: implications of immune reconstitution syndrome with indinavir-based regimen. Paedtr Infect Dis J 21: 435-8.
45. Voorter CE, Amicosante M, Berretta F et al. (2007). HLA class II amino acid epitopes as susceptibility markers of sarcoidosis. Tissue Antigens 70: 18-27.
46. Whitlock WL, Lowery WS, Dietrich RA (1990). Bronchoalveolar lavage in sarcoidosis and HIV infection. Chest 98: 517.
47. Wittram C, Fogg J, Farber H (2001). Immune restoration syndrome manifested by pulmonary sarcoidosis. Am J Roentgen 177: 1427.